Symbol="MNOV"
AssetType="Common Stock"
Name="MediciNova Inc"
Description="MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapies for the treatment of serious diseases with unmet medical needs in the United States. The company is headquartered in La Jolla, California."
CIK="1226616"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="120661000"
EBITDA="-14164497"
PERatio="None"
PEGRatio="-0.94"
BookValue="1.381"
DividendPerShare="0"
DividendYield="0"
EPS="-0.28"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.114"
ReturnOnEquityTTM="-0.184"
RevenueTTM="0"
GrossProfitTTM="4037500"
DilutedEPSTTM="-0.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2877.38"
PriceToBookRatio="1.691"
EVToRevenue="1142.72"
EVToEBITDA="-5.29"
Beta="0.977"
num_52WeekHigh="2.73"
num_52WeekLow="1.89"
num_50DayMovingAverage="2.266"
num_200DayMovingAverage="2.245"
SharesOutstanding="49049200"
DividendDate="None"
ExDividendDate="None"
symbol="MNOV"
open="2.47"
high="2.55"
low="2.40"
price="2.41"
volume="29280.00"
latest_trading_day="2023-07-18"
previous_close="2.46"
change="-0.05"
change_percent="-2.0325%"
aroon_positive_momentum_days="50"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="20740"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="499"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_negative_thumbnail_id_2="139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
